ask="266.00"
ask_size="300"
average_daily_volume="439756"
bid="16.26"
bid_size="200"
book_value="3.21"
change="-0.80"
change_from_200_day_moving_average="3.48"
change_from_50_day_moving_average="-1.43"
change_from_52_week_high="-4.78"
change_From_52_week_low="12.95"
change_in_percent="-4.05%"
close="18.97"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.48"
ebitda="-21.87M"
eps_estimate_current_year="-2.59"
eps_estimate_next_quarter="-0.59"
eps_estimate_next_year="-2.48"
ex_dividend_date="N/A"
float_shares="7150000"
high="19.90"
high_52_weeks="23.75"
last_trade_date="3/17/2017"
last_trade_price="18.97"
last_trade_size="4777"
last_trade_time="4:00pm"
low="18.86"
low_52_weeks="6.02"
market_capitalization="188.81M"
moving_average_200_day="15.49"
moving_average_50_day="20.40"
name="Zynerba Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.63"
open="19.75"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+22.47%"
percent_change_from_50_day_moving_average="-7.03%"
percent_change_from_52_week_high="-20.13%"
percent_change_from_52_week_low="+215.12%"
previous_close="19.77"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.16"
price_per_sales="3481.19"
revenue="56524.00"
shares_outstanding="9953000"
short_ratio="3.71"
stock_exchange="NGM"
symbol="ZYNE"
volume="378476"
weeks_range_52="6.02 - 23.75"
